SC 13G/A - Churchill Capital Corp VII (0001828248) (Subject)

SC 13G - Churchill Capital Corp VII (0001828248) (Subject)

SC 13G - Churchill Capital Corp VII (0001828248) (Subject)

SC 13G/A - Churchill Capital Corp VII (0001828248) (Subject)

SC 13G - Churchill Capital Corp VII (0001828248) (Subject)

SC 13G - Churchill Capital Corp VII (0001828248) (Subject)

SC 13G/A - Churchill Capital Corp VII (0001828248) (Subject)

SC 13G - Churchill Capital Corp VII (0001828248) (Subject)

SC 13G/A - Churchill Capital Corp VII (0001828248) (Subject)

SC 13G/A - Churchill Capital Corp VII (0001828248) (Subject)

In Excess of $605 Million Remains in Churchill VII's Trust Account after Stockholder Redemptions relating to the Extension

CorpAcq is a corporate compounder and preferred acquirer of founder-led small and medium-sized enterprises in the UK anchored by a diversified portfolio of 41 stable and profitable businesses Transaction is expected to provide CorpAcq with capital to optimize its balance sheet and the opportunity to fund accelerated growth and scale with a broader acquisition pipeline CorpAcq has grown revenue at an annual rate of 16% and adjusted EBITDA1 of 17% over the last 4 years including average organic revenue growth of 4% and subsidiary-level profit growth of 7%, respectively Transaction implies an initial enterprise value of approximately $1.58 billion, providing an attractive entry point for Chu

One of the biggest words for investors in 2021 was SPACs. While special purpose acquisition companies have been around for years, 2021 became the year that they took over the market in terms of IPOs and as a topic of conversation. There were over 600 new SPACs that went public in 2021 and over 150 deals that were announced last year. Here’s a look at what could be ahead for SPACs in 2022 from two well respected names in the SPAC coverage sector. The SPAC Experts: Benzinga talked 2021 SPAC deals and news items with Julian Klymochko, founder and CEO of Accelerate, and Nick Gershenhorn from SpacTrack.IO, a leading SPAC data and insights website. SPAC Offerings: Despite over 600 new SPAC offe

https://www.bloomberg.com/news/articles/2021-12-16/byju-s-is-said-in-talks-to-go-public-through-churchill-spac-deal?srnd=premium-asia&sref=ZoyErlU1

4 - Churchill Capital Corp VII (0001828248) (Issuer)

4 - Churchill Capital Corp VII (0001828248) (Issuer)

3 - Churchill Capital Corp VII (0001828248) (Issuer)

3 - Churchill Capital Corp VII (0001828248) (Issuer)

3 - Churchill Capital Corp VII (0001828248) (Issuer)

3 - Churchill Capital Corp VII (0001828248) (Issuer)

15-12G - Churchill Capital Corp VII (0001828248) (Filer)

8-K - Churchill Capital Corp VII (0001828248) (Filer)

25-NSE - Churchill Capital Corp VII (0001828248) (Subject)

10-Q - Churchill Capital Corp VII (0001828248) (Filer)

8-K - Churchill Capital Corp VII (0001828248) (Filer)

DEFA14A - Churchill Capital Corp VII (0001828248) (Filer)

DEFA14A - Churchill Capital Corp VII (0001828248) (Filer)

8-K - Churchill Capital Corp VII (0001828248) (Filer)

DEFA14A - Churchill Capital Corp VII (0001828248) (Filer)

DEFA14A - Churchill Capital Corp VII (0001828248) (Filer)

Churchill Announces Redemption of Public Shares NEW YORK and ALTRINCHAM, England, Aug. 18, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill") (NASDAQ:CVII), a publicly-traded special purpose acquisition company, and CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, today announced that they have mutually agreed to terminate their previously announced merger agreement (the "Merger Agreement") due to IPO market conditions, effective today. "While market conditions are not favorab

Stockholders may elect to redeem shares of Class A Common Stock until 5:00 pm Eastern Time, August 9, 2024 NEW YORK, Aug. 5, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") (NASDAQ:CVII), a special purpose acquisition company, announced today that the deadline for Churchill VII stockholders to elect redemption of their shares of class A common stock of Churchill VII ("Class A Common Stock") in connection with the proposed business combination between CorpAcq Holdings Limited ("CorpAcq"), and Churchill VII (the "Business Combination") is extended until 5:00 P.M., Eastern Time on August 9, 2024. The redemption deadline is being extended so that stockholders will have sufficie

Expected Financing Would De-Risk Closing of Business Combination and is Anticipated to Support CorpAcq's Future Growth NEW YORK and ALTRINCHAM, England, Aug. 2, 2024 /PRNewswire/ -- CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, and Churchill Capital Corp VII ("Churchill VII") (NASDAQ:CVII), a special purpose acquisition company, today provided an update on planned equity or equity-linked financing in support of the previously announced business combination (the "Business Combination") between CorpAcq, CorpAcq Group Plc, a public limited company incorporated under the laws of England and Wales and an

Redemption deadline for stockholders moved to August 8, 2024 NEW YORK, July 18, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") (Nasdaq: CVII), a special purpose acquisition company, announced today that it intends to adjourn each of the special meeting of Churchill VII stockholders (the "Stockholder Special Meeting") and the meeting of Churchill VII warrant holders (the "Warrant Holder Meeting"), which are currently scheduled for July 25, 2024, to be held in connection with the proposed business combination between CorpAcq Holdings Limited ("CorpAcq"), and Churchill VII (the "Business Combination"). The Stockholder Special Meeting will reconvene on August 12, 2024 at 10:0

Board of Directors Recommends Stockholders and Public Warrant Holders Vote "FOR" All Proposals NEW YORK and ALTRINCHAM, England, June 20, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") (Nasdaq: CVII), a special purpose acquisition company, announced today that it has scheduled a special meeting of Churchill VII stockholders (the "Stockholder Special Meeting") to be held in connection with the proposed business combination (the "Business Combination") between CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, and Churchill VII and a meeting of Churchill VII public warrant holders (the "

Board of Directors Recommends Stockholders and Warrant Holders Vote "FOR" All Proposals NEW YORK and ALTRINCHAM, England, March 22, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") (NASDAQ:CVII), a special purpose acquisition company, announced today that it has scheduled a special meeting of Churchill VII stockholders and a meeting of Churchill VII warrant holders for May 21, 2024 in connection with the proposed business combination between CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, and Churchill VII (the "Business Combination"). The Business Combination continues to progress an

In Excess of $605 Million Remains in Churchill VII's Trust Account after Stockholder Redemptions relating to the Extension NEW YORK, Feb. 12, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") (NASDAQ:CVII) announced today that in a special meeting of its stockholders ("Special Meeting"), Churchill VII's stockholders voted to approve a proposal to amend Churchill VII's certificate of incorporation and extend the date by which Churchill VII is required to consummate its initial business combination (the "Business Combination") with CorpAcq Holdings Limited ("CorpAcq") from February 17, 2024 to August 17, 2024 (or such earlier date as determined by the board of directors of Chur

Special meeting of stockholders of Churchill VII scheduled for February 8, 2024 to extend date by which Churchill VII must consummate its business combination with CorpAcq Holdings Limited NEW YORK, Jan. 30, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") announced today actions being undertaken in advance of a special meeting of its stockholders (the "Special Meeting") on February 8, 2024, at which Churchill VII's stockholders will be asked to vote on, among other things, a proposal to amend Churchill VII's amended and restated certificate of incorporation to extend the date by which Churchill VII has to consummate its business combination with CorpAcq Holdings Limited ("C

NEW YORK, Jan. 23, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") (NYSE:CVII), a special purpose acquisition company, announced today that it plans to transfer the listing of its shares of Class A common stock, public warrants and public units from the New York Stock Exchange ("NYSE") to Nasdaq Global Market ("Nasdaq"). Churchill VII expects that listing and trading of its securities on the NYSE will end at market close on February 2, 2024, and expects to commence trading as a Nasdaq-listed company upon market open on February 5, 2024. Churchill VII's Class A common stock, public units and public warrants will trade under the respective ticker symbols, "CVII," "CVIIU" and

ALTRINCHAM, England and NEW YORK, Jan. 22, 2024 /PRNewswire/ -- CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, today provided the following business update including: Reaffirming guidance for the full year ending December 31, 2023;Confirming on track timing of its Business Combination with Churchill Capital Corp VII ("Churchill VII") (NYSE:CVII);A successful refinancing of its group debt; andUpcoming Analyst Day. Management Reaffirms Financial Outlook for Full-Year 2023  Since the rele